With a background steeped in biopharmaceutical innovation, Ivan Kairatov is a leading expert in oncology therapeutics. His insights into the development and approval of new cancer treatments are invaluable, especially regarding the European Commission's recent decision on AstraZeneca's Calquence
The integrity of clinical trials remains an ever-present concern within the medical and scientific communities. One of the most pressing issues threatening this integrity is the participation of duplicate and professional research subjects. These individuals, who simultaneously or successively
Navigating the intricate landscape of healthcare demands more than just clinical expertise, as illustrated by the Health Service Executive (HSE) consultants grappling with the dual demands of stringent training requirements and clinical obligations. This challenge was vividly brought to light
The burgeoning demands of the healthcare industry have put the spotlight on sterile packaging, a pivotal element in ensuring the safety and efficacy of medical products and devices. As healthcare facilities worldwide grapple with escalating cases of chronic diseases, the need for impeccable
Clinical trials stand as a cornerstone in the journey toward medical advancements, acting as the bridge that connects theoretical research with practical, patient-centered care. At the University of Arkansas for Medical Sciences (UAMS), clinical trials are a celebrated and integral part of
The American Hospital Association (AHA) has put forth a series of recommendations aimed at reforming policies to mitigate health insurers' growing dominance in the market, focusing on recent developments that exacerbate competition challenges. The AHA has submitted these recommendations to the
